437 related articles for article (PubMed ID: 21737002)
21. Clinicopathologic challenge. Regional lymphomatoid papulosis, type A.
Sharma V; Xu G; Petronic-Rosic V; Gerami P
Int J Dermatol; 2007 Sep; 46(9):905-9. PubMed ID: 17822490
[No Abstract] [Full Text] [Related]
22. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
23. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
Slotosch CM; Hörster S; Hertl M; Schultz E
Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
[TBL] [Abstract][Full Text] [Related]
24. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
Gallardo F; Costa C; Bellosillo B; Solé F; Estrach T; Servitje O; García-Muret MP; Barranco C; Serrano S; Pujol RM
Acta Derm Venereol; 2004; 84(6):463-8. PubMed ID: 15844638
[TBL] [Abstract][Full Text] [Related]
25. Recurrent course and CD30 expression of atypical T lymphocytes distinguish lymphomatoid papulosis from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.
Tsujiwaki M; Abe R; Ohguchi Y; Hoshina D; Murata J; Fujita Y; Nomura T; Ambo M; Shimizu H
Acta Derm Venereol; 2014 Sep; 94(5):613-4. PubMed ID: 24549273
[No Abstract] [Full Text] [Related]
26. Lymphomatoid papulosis and cutaneous CD30+ lymphoma.
LeBoit PE
Am J Dermatopathol; 1996 Jun; 18(3):221-35. PubMed ID: 8806956
[TBL] [Abstract][Full Text] [Related]
27. [Clinical course and therapy of lymphomatoid papulosis. Experience with 17 cases and literature review].
Korpusik D; Ruzicka T
Hautarzt; 2007 Oct; 58(10):870-81. PubMed ID: 17486304
[TBL] [Abstract][Full Text] [Related]
28. Type B follicular lymphomatoid papulosis.
Chaudhari PR; Emanuel P; Levitt J
Cutis; 2010 Jun; 85(6):307-11. PubMed ID: 20666192
[TBL] [Abstract][Full Text] [Related]
29. Lymphomatoid papulosis and recurrent transitional cell carcinoma of the bladder: a paraneoplastic association.
Leon WM; Aw CW; Tran KB
Dermatol Online J; 2014 Apr; 20(4):22369. PubMed ID: 24746306
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
[TBL] [Abstract][Full Text] [Related]
31. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
[TBL] [Abstract][Full Text] [Related]
32. Three cases of lymphomatoid papulosis with a CD56+ immunophenotype.
Flann S; Orchard GE; Wain EM; Russell-Jones R
J Am Acad Dermatol; 2006 Nov; 55(5):903-6. PubMed ID: 17052504
[TBL] [Abstract][Full Text] [Related]
33. [Item 164--Malignant lymphomas: cutaneous lymphomas].
CEDEF
Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
[No Abstract] [Full Text] [Related]
34. Lymphomatoid papulosis showing γδ T-cell phenotype.
Morimura S; Sugaya M; Tamaki Z; Takekoshi T; Sato S
Acta Derm Venereol; 2011 Oct; 91(6):712-3. PubMed ID: 21629977
[No Abstract] [Full Text] [Related]
35. Persistent agmination of lymphomatoid papulosis: a new case with immunohistopathologically confirmed mycosis fungoides component.
Csomor J; Erős N; Szepesi Á; Csernus B; Szakonyi J; Kontár O; Matolcsy A; Kárpáti S; Marschalkó M
J Am Acad Dermatol; 2011 Sep; 65(3):e98-e100. PubMed ID: 21839314
[No Abstract] [Full Text] [Related]
36. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8
Deenen NJ; Koens L; Jaspars EH; Vermeer MH; Willemze R; de Rie MA; Bekkenk MW
Br J Dermatol; 2019 Feb; 180(2):411-412. PubMed ID: 30259963
[No Abstract] [Full Text] [Related]
37. [CD56-positive 'natural killer'/T-cell lymphoma].
Bekkenk MW; Willemze R
Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1524-5. PubMed ID: 11569462
[No Abstract] [Full Text] [Related]
38. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.
Delfau-Larue MH; Laroche L; Wechsler J; Lepage E; Lahet C; Asso-Bonnet M; Bagot M; Farcet JP
Blood; 2000 Nov; 96(9):2987-92. PubMed ID: 11049975
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
40. Practical Management of CD30⁺ Lymphoproliferative Disorders.
Hughey LC
Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
